1 completed. 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Completed 1 |
Follow Cessation Therapeutics, Inc.: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Safety, Tolerability, and Pharmacokinetics of CSX-1004 CSX-1004, Placebo - Opioid Overdose, Opioid Use Disorder | Phase 1 | Completed | Cessation Therapeutics, Inc. | 32 | 2023-08-01 | 2024-08-21 |
Opiate Overdose (1) · Opioid-Related Disorders (1)
United States (1)
Steven Hull, MD (1)